Fortive Corporation (FTV) Earnings: Q3 2026 Results

The quarter ended October 2, 2026 and Fortive published the results on October 28, 2026. Revenue and diluted EPS are shown against Q3 2025, the same quarter a year earlier, which takes seasonal swings out of the comparison. Fortive reports EPS two ways: GAAP, under the accounting rules every US filer follows, and adjusted, which leaves out items the company considers outside its operating results. The release reconciles the two, and when they diverge, the reconciliation says why.

• Fortive spun off its Precision Technologies segment as Ralliant on June 28, 2025. Revenue, EPS and net earnings on this page are from continuing operations. Including discontinued operations, Q3 2025 diluted EPS was $0.16.
• Fortive's adjusted figures exclude $18.0 million of pretax IEEPA tariff refunds recognized in Q3 2026 cost of sales, after the Supreme Court decision of February 20, 2026.

Source: Fortive Q3 2026 results, October 28, 2026. Also in the Form 10-Q for the quarter ended October 2, 2026. Figures as reported; checked against the release on November 10, 2026.

How Fortive splits revenue in its own release, under its own labels, for Q3 2026 against Q3 2025. Indented lines are parts of the line above them.

• Fortive's Intelligent Operating Solutions revenue was $767 million in Q3 2026, up 10% from $699 million in Q3 2025, 69% of total revenue.
• Fortive's Advanced Healthcare Solutions revenue was $340 million in Q3 2026, up 4% from $328 million in Q3 2025, 31% of total revenue.

Segment lines are the figures writers cite most often, because they show where the growth in a quarter came from. Companies redraw their segments from time to time and restate the prior year to match, so a year-ago figure here can differ from the one printed a year ago. When that has happened, the note above says so.

From the earnings release

Fortive's Q3 2026 release gives an adjusted EPS range for the year and no revenue outlook.

In its Q3 2026 release, Fortive said:

“For FY 2026, Fortive now expects adjusted diluted earnings per share of $3.10 to $3.14.”

Source: Fortive Q3 2026 release, Oct 28, 2026.

This is the company's own guidance as of Oct 28, 2026, quoted as given. Walnut does not make forecasts of its own. Analyst estimates for the coming quarters are on the FTV forecast page.

Revenue and diluted EPS for the last 5 quarters. Each date links to that quarter's release.

GAAP sales and diluted EPS from continuing operations, each as first reported in that quarter's release. Including discontinued operations, diluted EPS was $0.58 in Q4 2025 and $0.16 in Q3 2025.

We do not hold a confirmed date for Fortive's next report. Companies post the date on their investor relations site a few weeks ahead, usually with the time of the conference call.

Each quarter keeps its own page with the figures as reported, so a link to one stays pointed at the same numbers after the next report.

• Q3 2026 (this page), reported Oct 28, 2026

Fortive has two segments since the Ralliant spin-off. In Q3 2026 Intelligent Operating Solutions had sales of $767.1 million and Advanced Healthcare Solutions $340.4 million, for a total of $1,107.5 million, up 7.8% from $1,027.1 million. Core revenue, which excludes acquisitions, divestitures and currency, grew 7.2%. (Fortive Q3 2026 release, Oct 28, 2026)

Intelligent Operating Solutions sells professional instruments, facility and asset lifecycle software and connected worker safety products under brands including Fluke, ServiceChannel, Gordian, Accruent, Industrial Scientific and Intelex. Advanced Healthcare Solutions sells instrument sterilization, instrument tracking, biomedical test tools, radiation monitoring and clinical software under brands including ASP, Censis, Fluke Biomedical, Landauer and Provation. (Fortive Form 10-K, 2025, Feb 25, 2026)

Intelligent Operating Solutions grew 9.1% on a core basis, from pricing of 2.1% and volume growth of 7.0%; Fortive named professional instrumentation as the largest contributor, with facilities and asset lifecycle software and gas detection also growing. Advanced Healthcare Solutions grew 3.1% on a core basis, from pricing of 2.8% and volume of 0.3%, led by sterilization products. (Fortive Form 10-Q, Q3 2026, Oct 28, 2026; Fortive Q3 2026 release, Oct 28, 2026)

North America (the United States and Canada) supplied $678.1 million of sales, and the United States alone 58%. By end market, Healthcare was $331.6 million and Industrial & Manufacturing $322.4 million. Products and software were $884.6 million and services $222.9 million. (Fortive Form 10-Q, Q3 2026, Oct 28, 2026)

Fortive's GAAP diluted EPS from continuing operations was $0.57 in Q3 2026, against $0.35, and adjusted diluted EPS was $0.77, against $0.68. The largest adjustment is $89.3 million of pretax amortization of acquisition related intangible assets, or $0.29 per share. Adjusted EPS also excludes the $18.0 million of IEEPA tariff refunds ($0.06) and a $6.2 million capitalized software impairment ($0.02). (Fortive Q3 2026 release, Oct 28, 2026)

The year-ago GAAP figure carried $38.3 million of acquisition, divestiture and Separation related items ($0.11 per share), and Fortive's corporate Other line that quarter included $33 million of stock based compensation expense from adjustments made in connection with the Ralliant spin-off. The effective tax rate was 14.7%, against 13.3%. (Fortive Q3 2026 release, Oct 28, 2026; Fortive Form 10-Q, Q3 2026, Oct 28, 2026)

Buybacks cut the share count. Diluted shares were 303.9 million, down from 333.4 million. Fortive repurchased about $300 million of shares in the quarter and 17.2 million shares for about $1.0 billion in the first nine months of 2026. (Fortive Q3 2026 release, Oct 28, 2026; Fortive Form 10-Q, Q3 2026, Oct 28, 2026)

Diluted EPS divides net income by the weighted average number of shares outstanding in the quarter, plus the shares that options and other equity awards could add. Buybacks shrink that count and lift EPS for the same profit; share issuance and stock awards enlarge it.

Fortive gives an adjusted EPS range in its release. After Q3 2026 it raised its full-year 2026 range to $3.10 to $3.14, which it described as up about 15% year over year at the midpoint. The release gives no revenue outlook. (Fortive Q3 2026 release, Oct 28, 2026)

A consensus figure is the average of the models published by the analysts who cover Fortive, collected by a data provider and revised up to the day of the report. A quarter that lands above it says how expectations were set as much as how the business did, and the share price on the day also reflects the guidance and the lines no consensus covers.

The consensus figures on this page are Yahoo Finance's, as pulled on the date shown. Each comes with the number of analysts behind it; the smaller that number, the more one revised estimate can move the average.

The figures below are the ones Fortive's own release and filings put weight on for Q3 2026, with the latest reported value for each.

What the quarter means for a holding is a separate question from what it reported. The case for and against owning FTV is on is FTV a buy or a sell?, what analysts expect next is on the FTV forecast, and what the company does is on the Fortive Corporation (FTV) stock page.

Every number on this page can be traced to a document Fortive published. Checking one takes a couple of minutes, and it is worth doing before you quote a figure anywhere.

• The results release is the document linked in the source line above. Companies publish it on their investor relations site at the moment results go out, and it carries the headline tables: revenue, operating income, net income and EPS for the quarter and the year-ago quarter.
• The same release is filed with the SEC as Exhibit 99.1 to a Form 8-K under Item 2.02, usually on the day of the report. The SEC copy does not change after the fact, which makes it the safer thing to link when you cite a number.
• The quarterly report (Form 10-Q) follows within a few weeks and carries the full financial statements, the segment note and management's discussion of what changed. The fourth quarter is covered by the annual report (Form 10-K) instead.
• Restated comparisons are flagged in the notes on this page. When a company redraws its segments or changes how it adjusts EPS, it restates the year-ago column, so the year-ago figure in a new release can differ from the one printed a year ago. This page always uses the comparison in the newer release, because that is the like-for-like one.

A walk-through of every line in a release, with what each one tells you, is in how to read an earnings report.